Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Study ID: NCT07293364
Start Date: 2026-03-01
End Date: 2027-01-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

514

Intervention / Treatment

Technochrom C1-INH Kit

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Preventing Early-Onset Colorectal Cancer in the VA

Study ID: NCT07071454
Start Date: 2026-07-01
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

536

Intervention / Treatment

Patient intervention

PCP intervention

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

CKM For Safe Use of SGLT2i in Type 1 Diabetes

Study ID: NCT07211802
Start Date: 2026-07-01
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

52

Intervention / Treatment

Sotagliflozin Low Dose

Sotagliflozin High Dose

Dual Continuous Glucose and Ketone Monitor

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

Impact of Seed Cycling on Menstrual Regularity, Dysmenorrhea, and Premenstrual Symptoms

Study ID: NCT07052500
Start Date: 2026-05
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Seed Cycling

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

Mode of Ventilation During Critical Illness at Multiple Centers

Study ID: NCT07313956
Start Date: 2027-07
End Date: 2030-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4785

Intervention / Treatment

Volume control

Pressure control

Adaptive pressure control

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Study ID: NCT06900595
Start Date: 2026-07-19
End Date: 2029-06-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Biospecimen Collection

Cabozantinib

Cemiplimab

Computed Tomography

Magnetic Resonance Imaging

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination

Study ID: NCT07300930
Start Date: 2026-03-01
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

216

Intervention / Treatment

SMARTwrap

Sponsor

3-C Institute for Social Development

Source: clinicaltrials.gov

Share:
Add to list

A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)

Study ID: NCT05793567
Start Date: 2026-08
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment

Coronary angiogram with coronary reactivity testing (CRT)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

Study ID: NCT07018739
Start Date: 2026-06
End Date: 2033-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Wharton's jelly-derived mesenchymal stem cells

0.9 % Normal Saline

Sponsor

Mahidol University

Source: clinicaltrials.gov

Share:
Add to list

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

Study ID: NCT07257068
Start Date: 2026-04-14
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

14

Intervention / Treatment

Infliximab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list